TIAA CREF Investment Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $236K | Sell |
59,473
-20,930
| -26% | -$83.1K | ﹤0.01% | 2854 |
|
|
2018
Q4 | $320K | Buy |
80,403
+20,930
| +35% | +$83.3K | ﹤0.01% | 2750 |
|
|
2018
Q3 | $409K | Sell |
59,473
-2,470
| -4% | -$17K | ﹤0.01% | 2798 |
|
|
2018
Q2 | $418K | Sell |
61,943
-9,144
| -13% | -$61.7K | ﹤0.01% | 2855 |
|
|
2018
Q1 | $463K | Buy |
71,087
+18,736
| +36% | +$122K | ﹤0.01% | 2771 |
|
|
2017
Q4 | $233K | Sell |
52,351
-3,368
| -6% | -$15K | ﹤0.01% | 2986 |
|
|
2017
Q3 | $344K | Sell |
55,719
-55,300
| -50% | -$341K | ﹤0.01% | 2970 |
|
|
2017
Q2 | $1.03M | Buy |
111,019
+785
| +0.7% | +$7.28K | ﹤0.01% | 2531 |
|
|
2017
Q1 | $1.02M | Buy |
110,234
+34,449
| +45% | +$320K | ﹤0.01% | 2492 |
|
|
2016
Q4 | $634K | Sell |
75,785
-1,150
| -1% | -$9.62K | ﹤0.01% | 2750 |
|
|
2016
Q3 | $529 | Hold |
76,935
| – | – | ﹤0.01% | 2827 |
|
|
2016
Q2 | $381K | Buy |
76,935
+28,467
| +59% | +$141K | ﹤0.01% | 2969 |
|
|
2016
Q1 | $468K | Hold |
48,468
| – | – | ﹤0.01% | 2805 |
|
|
2015
Q4 | $454K | Sell |
48,468
-9,504
| -16% | -$89K | ﹤0.01% | 2921 |
|
|
2015
Q3 | $815K | Buy |
57,972
+5,879
| +11% | +$82.7K | ﹤0.01% | 2689 |
|
|
2015
Q2 | $1.1M | Buy |
52,093
+29,910
| +135% | +$629K | ﹤0.01% | 2647 |
|
|
2015
Q1 | $931K | Buy |
22,183
+10,154
| +84% | +$426K | ﹤0.01% | 2654 |
|
|
2014
Q4 | $283K | Buy |
12,029
+1,490
| +14% | +$35.1K | ﹤0.01% | 3063 |
|
|
2014
Q3 | $158K | Buy |
+10,539
| New | +$158K | ﹤0.01% | 3097 |
|